Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Zepp Health (ZEPP) over the last 10 years, with Q3 2025 value amounting to $274.7 billion.

  • Zepp Health's Non-Current Assets rose 20045.48% to $274.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $554.1 billion, marking a year-over-year increase of 14772.98%. This contributed to the annual value of $87.2 million for FY2024, which is 1943.99% down from last year.
  • Latest data reveals that Zepp Health reported Non-Current Assets of $274.7 billion as of Q3 2025, which was up 20045.48% from $276.5 billion recorded in Q2 2025.
  • Zepp Health's 5-year Non-Current Assets high stood at $330.9 billion for Q2 2023, and its period low was -$651.9 billion during Q2 2021.
  • In the last 5 years, Zepp Health's Non-Current Assets had a median value of -$269.8 billion in 2024 and averaged -$173.2 billion.
  • In the last 5 years, Zepp Health's Non-Current Assets tumbled by 17475164.22% in 2022 and then surged by 20250.15% in 2025.
  • Quarter analysis of 5 years shows Zepp Health's Non-Current Assets stood at $109.7 million in 2021, then increased by 1.29% to $111.1 million in 2022, then fell by 3.95% to $106.7 million in 2023, then decreased by 18.3% to $87.2 million in 2024, then soared by 315002.22% to $274.7 billion in 2025.
  • Its Non-Current Assets was $274.7 billion in Q3 2025, compared to $276.5 billion in Q2 2025 and $276.3 billion in Q1 2025.